SUN PHARMACEUTICAL IND L vs Vivanza Biosciences Ltd

A side-by-side comparison of SUN PHARMACEUTICAL IND L (SUNPHARMA) and Vivanza Biosciences Ltd (VIVANZABIOSCIENCESLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, SUN PHARMACEUTICAL IND L leads SUNPHARMA vs VIVANZABIOSCIENCESLTD on 10 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability40
  • Growth01
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

40.39
P/E ratio
16.20
20.07
P/B ratio
1.63
0.84%
Dividend yield
0.00%
₹47.84
EPS
₹0.10

Profitability

SUNPHARMA takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.00%
Return on equity
9.38%
21.00%
Return on capital
6.00%
30.00%
EBITDA margin
1.00%
19.69%
Net margin
0.00%

Growth

VIVANZABIOSCIENCESLTD takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.03%
Revenue CAGR (3Y)
86.09%
10.57%
Profit CAGR (3Y) even

Size & financial health

SUNPHARMA takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.63L Cr
Market cap
₹7 Cr
₹58,462 Cr
Revenue
₹116 Cr
₹11,509 Cr
Net profit
₹0 Cr
0.61
Debt / equity
2.00
SUN PHARMACEUTICAL IND L
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
  • ["The company has delivered a poor sales growth of 11.8% over past five years."]
Vivanza Biosciences Ltd
  • + ["Debtor days have improved from 196 to 39.0 days."]
  • ["Promoter holding is low: 20.0%", "Company has a low return on equity of 2.11% over last 3 years.", "Company might be capitalizing the interest cost", "Promoter holding has decreased over last 3 years: -27.8%"]
SUN PHARMACEUTICAL IND L full analysis Vivanza Biosciences Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.